The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Lichtinger Pedro since year 2005.
The trader's CIK number is 1470741.
At the time of this reporting, Lichtinger Pedro is the Director of Gemphire Therapeutics Inc. .
(stock ticker symbol GEMP).
See this page for all insider trading activities at Gemphire Therapeutics Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-03-10||GEMP||Gemphire Therapeutics Inc.||Buy||10,559||9.47||99,993|
|2016-08-10||GEMP||Gemphire Therapeutics Inc.||Buy||10,000||10.00||100,000|
|2015-02-09||AST||Asterias Biotherapeutics, Inc.||Buy||128,205||3.90||499,999|
|2013-04-08||OPTR||Optimer Pharmaceuticals Inc||Sale||148,000||14.68||2,172,344|
|2013-04-08||OPTR||Optimer Pharmaceuticals Inc||Option Ex||148,000||12.46||1,844,080|
|2012-11-08||OPTR||Optimer Pharmaceuticals Inc||Buy||11,000||9.08||99,847|
|2011-08-04||OPTR||Optimer Pharmaceuticals Inc||Buy||25,000||8.98||224,450|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lichtinger Pedro (Director of Gemphire Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.